RKLB: Major Pullback Into My Accumulation Zone | $110–$160Rocket Lab CorporationBATS:RKLBAdlercon333Rocket Lab has undergone a major correction after reaching approximately $150, bringing the stock back into an area where I believe long-term investors can begin building a position gradually. The larger trend has been exceptionally strong, but RKLB became extended and needed time to reset. This decline does not automatically mean the long-term thesis is broken—it means patience and position sizing matter. My accumulation zones: Zone 1: $40–$55 — Best Value This is the strongest value area on my chart and where I would be most interested in adding. A deeper decline into this zone would offer the best risk-to-reward, assuming the company’s fundamentals remain intact. Zone 2: $55–$68 — Build the Position RKLB is currently trading inside this area. I view this as a reasonable place to begin accumulating gradually, but not an area where I would deploy the entire position at once. Zone 3: $68–$85 — Trend Confirmation A recovery into this zone, followed by constructive price action, would suggest buyers are regaining control. The tradeoff is paying a higher price for greater technical confirmation. Why I remain bullish long term: Rocket Lab reported record first-quarter revenue of $200.3 million. Backlog reached more than $2.2 billion. The company continues expanding across launch services, space systems and defense. Government demand and major contract opportunities remain important growth drivers. Neutron could materially expand Rocket Lab’s addressable market if development and execution remain successful. Long-term target: $110–$160+ I believe this range becomes reasonable if Rocket Lab continues growing revenue, executes on its backlog and successfully expands its launch and space-systems operations. This is a long-term target—not a prediction that the stock moves there immediately. What would invalidate the setup? A decisive breakdown below $40. Material deterioration in revenue growth or backlog. Major delays or execution problems involving Neutron. Financing, dilution or acquisition-related risks that substantially weaken the investment thesis. My approach: I am not trying to pick the exact bottom. I would rather build gradually through the identified zones and preserve capital for additional volatility. This is a high-growth company with high expectations already reflected in its valuation. The upside could be significant, but so can the drawdowns. For educational purposes only. This is my personal market analysis, not financial advice. Always conduct your own research.